ArticleIMPACT OF DAPAGLIFLOZIN ON APOPTOSIS AND EFFECTOR CYTOTOXIC CELLS USING BREAST CANCER CELLS IN MICE
ArticleIMPACT OF DAPAGLIFLOZIN ON APOPTOSIS AND EFFECTOR CYTOTOXIC CELLS USING BREAST CANCER CELLS IN MICE
ArticleEffect of Dapagliflozin on Left Atrial Strain Parameters in Diabetic Patients with Paroxysmal Atrial Fibrillation
ArticleEffect of Dapagliflozin on Left Atrial Strain Parameters in Diabetic Patients with Paroxysmal Atrial Fibrillation
ArticleDapagliflozin's Impact on Cardio-Renal Outcomes in Critically Ill Type 2 Diabetes Mellitus Patients
ArticleDapagliflozin's Impact on Cardio-Renal Outcomes in Critically Ill Type 2 Diabetes Mellitus Patients
ArticleThe early effect of dapagliflozin on diastolic function parameters in patients with mid range and reduced ejection fraction heart failure
ArticleThe early effect of dapagliflozin on diastolic function parameters in patients with mid range and reduced ejection fraction heart failure
ArticleThe Effect of SGLT2 Inhibitors on the Development of Contrast-Induced Nephropathy in Diabetic Patients with Non-ST Segment Elevation Myocardial Infarction
ArticleThe Effect of SGLT2 Inhibitors on the Development of Contrast-Induced Nephropathy in Diabetic Patients with Non-ST Segment Elevation Myocardial Infarction
ArticleReno Protective Effect of Sodium Glucose Cotransporter-2 Inhibitor (Dapagliflozin) in Type 2 Diabetic Patients
ArticleReno Protective Effect of Sodium Glucose Cotransporter-2 Inhibitor (Dapagliflozin) in Type 2 Diabetic Patients
ArticleEffect of Sodium Glucose Co-transporter Type 2 Inhibitors on The Infract size among Diabetic Patients With ST Segment Elevation Myocardial Infarction Undergoing Primary Percutane
ArticleEffect of Sodium Glucose Co-transporter Type 2 Inhibitors on The Infract size among Diabetic Patients With ST Segment Elevation Myocardial Infarction Undergoing Primary Percutane
ArticleExploring the role of Glucagon-Like Peptide-1 in heart failure with preserved ejection fraction among patients with type 2 Diabetes Mellitus
ArticleExploring the role of Glucagon-Like Peptide-1 in heart failure with preserved ejection fraction among patients with type 2 Diabetes Mellitus